OpenEvidence, which Forbes profiled in July, has been signing up users fast. Its ultimate goal: To not just help doctors find existing medical research, but to create medical superintelligence.
Buyout marks the largest medical devices deal since 2006 Private equity firms capitalize on undervalued healthcare assets Improving credit markets enabling larger buyouts The buyout shows how the ...
For a really long time, if you wanted to use Microsoft Office tools like MS Word, Excel or PowerPoint, you needed to purchase a license for the software. Or you could subscribe to Microsoft 365. But ...
Honkai: Star Rail just closed out its version 3.7 livestream, teasing what’s to come in the next update, which launches the evening of Nov. 4. Alongside new characters and events, Hoyoverse uses the ...
There are a growing number of tablets with E Ink displays and digital pens that promise a paper-like experience for writing notes and drawing pictures. And at first ...
Much of the yellow metal rally “is being driven by physical buying, and if you look at central banks, they are going out and buying huge quantities,” Trafigura Group's chief economist Saad Rahim was ...
India's exports to the US have plummeted by 20.3% in September 2025, reaching $5.5 billion, due to Washington's imposition of 50% tariffs. This marks the fourth consecutive monthly decline, erasing ...
Simply sign up to the UK inflation myFT Digest -- delivered directly to your inbox. UK inflation unexpectedly held steady at 3.8 per cent in September, sparking a rally in gilts as traders bet the ...
Nvidia looks well positioned to keep benefiting from the artificial intelligence infrastructure buildout. Meta Platforms has been seeing strong momentum in its ad business. Microsoft has been firing ...
Google today announced Veo 3.1 as its latest video generation model, with Flow getting a number of updates to take advantage of the latest capabilities. Compared to Veo 3, which was announced at I/O ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback